---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-004025"
form_type: "8-K"
ticker: "INBS"
cik: "0001725430"
company_name: "INTELLIGENT BIO SOLUTIONS INC."
filed_at: "2025-01-28T23:59:59+00:00"
generated_at: "2026-05-27T08:24:58.176145+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Intelligent Bio Solutions partners with IVY Diagnostics to expand EU & Middle East drug screening market

## Summary
- Partnership with IVY Diagnostics Srl as key distributor for fingerprint drug screening in Europe and Middle East.
- IVY Diagnostics secured a tender for drug rehab programs across Italy using INBS' fingerprint drug screening technology.
- INBS' drug screening system undergoing trial with Turin police for roadside screening to test fingerprint-based method.
- Expansion to multiple countries: Romania, Hungary, Slovakia, Austria, Scandinavia, UAE, Saudi Arabia, Qatar.
- European drug screening market projected at $3.6B by 2030; Middle East & Africa at $432.7M (Grand View Research).

## SEC filing metadata
- accession: 0001493152-25-004025
- form_type: 8-K
- ticker: INBS
- cik: 0001725430
- company_name: INTELLIGENT BIO SOLUTIONS INC.
- filed_at: 2025-01-28T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1725430/000149315225004025/0001493152-25-004025-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1725430/000149315225004025/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-004025
- JSON: https://secwatch.observer/filing/0001493152-25-004025.json
- Plain text: https://secwatch.observer/filing/0001493152-25-004025.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.